AskTheDate.com
Back to calendar

Allogene Therapeutics, Inc. (ALLO) Earnings

ALLO reports earnings on Thursday, October 29, 2026

earnings report
October 29, 2026 · Before Market Open
Q3 2026
Est. EPS: $-0.15
Actual EPS: $-0.13
EPS surprise: 24.14%
Company overview
Market Cap$691.0M
PriceUSD 2.00
EPS (TTM)-0.67
52-week high4.46
52-week low1.04
SectorHealth Technology
IndustryBiotechnology
Employees152
Buy me a coffee